Cihan Ay

21.3k citations
412 papers · 16.1k · 13 hit papers · h-index 63

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Hematology top 0.2%
    • Blood Coagulation and Thrombosis Mechanisms
    • Platelet Disorders and Treatments

Papers in

    • Venous Thromboembolism Diagnosis and Management 190
    • Blood Coagulation and Thrombosis Mechanisms 55
    • Platelet Disorders and Treatments 40
    • Hemophilia Treatment and Research 38

Cihan Ay

392 papers receiving 15.7k citations

Cihan Ay's Hit Papers

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism 2025 · 63 citations
630+5+11Years since publication200400600

Peers

Cihan Ay
Comparison fields: 5 of 135
  • Internal Medicine 8.4k
  • Hematology 3.3k
  • Emergency Medical Services 1.5k
  • Cardiology and Cardiovascular Medicine 4.2k
  • Genetics 866
Replace Anna Falanga with:
Anna Falanga Italy
Ingrid Pabinger Austria
Alok A. Khorana United States
Charles W. Francis United States
Michael Blake Streiff United States
Agnes Lee Canada
Frederick R. Rickles United States
Wendy Lim Canada
Paolo Simioni Italy
Ross Ian Baker Australia
Cihan Ay relative to Anna Falanga Italy Anna Falanga's profile →
Citations per field
00.5×1.5×1.9×
Anna Falanga · 1×
Citations per year

Countries citing papers authored by Cihan Ay

Since Specialization
Citations

This map shows the geographic impact of Cihan Ay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cihan Ay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cihan Ay more than expected).

Fields of papers citing papers by Cihan Ay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cihan Ay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cihan Ay. The network helps show where Cihan Ay may publish in the future.

Co-authors

The 25 scholars most cited alongside Cihan Ay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cihan Ay Line = papers co-authored together Cihan Ay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 412 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prediction of venous thromboembolism in cancer patients
Hit paper breakdown →
2010644
2
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Hit paper breakdown →
2021614
3
Venous thromboembolism in cancer patients: a population-based cohort study
Hit paper breakdown →
2020504
4
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Hit paper breakdown →
2019485
5
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Hit paper breakdown →
2016389
6 2008360
7
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
Hit paper breakdown →
2020356
8
D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study
Hit paper breakdown →
2009352
9
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Hit paper breakdown →
2022299
10 2012274
11
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Hit paper breakdown →
2018273
12 2012250
13 2018248
14
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
Hit paper breakdown →
2023243
15 2009210
16
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Hit paper breakdown →
2021203
17 2013200
18 2011198
19 2017198
20
Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life
Hit paper breakdown →
2022188

About Cihan Ay

Cihan Ay is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Emergency Medical Services and Oncology, having authored 412 papers that have together received 16.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (190 papers), Blood Coagulation and Thrombosis Mechanisms (55 papers), Atrial Fibrillation Management and Outcomes (42 papers), Platelet Disorders and Treatments (40 papers), Hemophilia Treatment and Research (38 papers), Central Venous Catheters and Hemodialysis (27 papers), Inflammatory Biomarkers in Disease Prognosis (27 papers) and Antiplatelet Therapy and Cardiovascular Diseases (17 papers). The work is most often cited by research in Internal Medicine (8.4k citations), Hematology (3.3k citations), Emergency Medical Services (1.5k citations), Cardiology and Cardiovascular Medicine (4.2k citations) and Genetics (866 citations). Cihan Ay has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Ingrid Pabinger, Christoph Carl Zielinski, Johannes Thaler, Florian Moik, Peter Quehenberger, Florian Posch, Daniela Dunkler, Ralph Simanek, Rainer Vormittag and Christine Marosi. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis Research, Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact